Show simple item record

dc.contributor.authorAuthorAcuña-Castillo, Claudio.
dc.contributor.authorAuthorBarrera-Avalos, Carlos.
dc.contributor.authorAuthorBachelet, Vivienne C.
dc.contributor.authorAuthorMilla. Luis A.
dc.contributor.authorAuthorInostroza-Molina, Ailén.
dc.contributor.authorAuthorVidal, Mabel
dc.contributor.authorAuthorLuraschi, Roberto
dc.contributor.authorAuthorVallejos-Vidal, Eva
dc.contributor.authorAuthorMella-Torres, Andrea.
dc.contributor.authorAuthorValdés, Daniel
dc.contributor.authorAuthorReyes-López, Felipe E.
dc.contributor.authorAuthorImarai, Mónica
dc.contributor.authorAuthorRojas, Patricio
dc.contributor.authorAuthorSandino, Ana María
dc.date.accessionedDate Accessioned2024-09-03T19:19:08Z
dc.date.availableDate Available2024-09-03T19:19:08Z
dc.date.issuedDate Issued2023
dc.identifier.citationReferencia BibliográficaFrontiers in Public Health, 11, 12 p.
dc.identifier.issnISSN2296-2565
dc.identifier.uriURIhttp://repositorio.udla.cl/xmlui/handle/udla/1416
dc.identifier.uriURIhttps://www.frontiersin.org/journals/public-health
dc.description.abstractAbstractIntroduction: As the SARS-CoV-2 continues to evolve, new variants pose a significant threat by potentially overriding the immunity conferred by vaccination and natural infection. This scenario can lead to an upswing in reinfections, amplified baseline epidemic activity, and localized outbreaks. In various global regions, estimates of breakthrough cases associated with the currently circulating viral variants, such as Omicron, have been reported. Nonetheless, specific data on the reinfection rate in Chile still needs to be included. Methods: Our study has focused on estimating COVID-19 reinfections per wave based on a sample of 578,670 RT-qPCR tests conducted at the University of Santiago of Chile (USACH) from April 2020 to July 2022, encompassing 345,997 individuals. Results: The analysis reveals that the highest rate of reinfections transpired during the fourth and fifth COVID-19 waves, primarily driven by the Omicron variant. These findings hold despite 80% of the Chilean population receiving complete vaccination under the primary scheme and 60% receiving at least one booster dose. On average, the interval between initial infection and reinfection was found to be 372 days. Interestingly, reinfection incidence was higher in women aged between 30 and 55. Additionally, the viral load during the second infection episode was lower, likely attributed to Chile's high vaccination rate. Discussion: This study demonstrates that the Omicron variant is behind Chile's highest number of reinfection cases, underscoring its potential for immune evasion. This vital epidemiological information contributes to developing and implementing effective public health policies.
dc.format.extentdc.format.extent12 páginas
dc.format.extentdc.format.extent2.919Mb
dc.format.mimetypedc.format.mimetypePDF
dc.language.isoLanguage ISOeng
dc.publisherPublisherFrontiers Media SA
dc.rightsRightsCreative Commons Attribution License (CC BY)
dc.sourceSourcesFrontiers in Public Health
dc.subjectSubjectReinfection
dc.subjectSubjectSARS-CoV-2
dc.subjectSubjectVariants of concern
dc.subject.lcshdc.subject.lcshCOVID-19 pandemia, 2020-
dc.subject.lcshdc.subject.lcshVacunas
dc.titleTitleAn ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile
dc.typeDocument TypeArtículo
dc.udla.catalogadordc.udla.catalogadorCBM
dc.udla.indexdc.udla.indexScience Citation Index Expanded
dc.udla.indexdc.udla.indexScopus
dc.udla.indexdc.udla.indexSocial Sciences Citation Index
dc.udla.indexdc.udla.indexDOAJ
dc.udla.indexdc.udla.indexEMBASE
dc.udla.indexdc.udla.indexMEDLINE
dc.udla.indexdc.udla.indexPsycinfo
dc.identifier.doidc.identifier.doi10.3389/fpubh.2023.1191377
dc.facultaddc.facultadFacultad de Medicina Veterinaria y Agronomía


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record